BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34798484)

  • 21. IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma.
    Zheng Y; Li Y; Tang B; Zhao Q; Wang D; Liu Y; Guo M; Zhao S; Qi Y; Zhang Y; Huang L
    Cancer Immunol Immunother; 2020 Nov; 69(11):2371-2380. PubMed ID: 32524362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial.
    Wang S; Lin Y; Xiong X; Wang L; Guo Y; Chen Y; Chen S; Wang G; Lin P; Chen H; Yeung SJ; Bremer E; Zhang H
    Clin Cancer Res; 2020 Sep; 26(18):4921-4932. PubMed ID: 32646922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of potential biomarkers associated with immune infiltration in the esophageal carcinoma tumor microenvironment.
    Wang Z; Chen M; Qiu Y; Yang Y; Huang Y; Li X; Zhang W
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33543230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
    Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
    Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.
    Zhang CY; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
    Biomed Pharmacother; 2015 Feb; 69():242-8. PubMed ID: 25661365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53.
    Chen Y; Xin H; Peng H; Shi Q; Li M; Yu J; Tian Y; Han X; Chen X; Zheng Y; Li J; Yang Z; Yang L; Hu J; Huang X; Liu Z; Huang X; Zhou H; Cui X; Li F
    Cancer Res; 2020 Jun; 80(11):2175-2189. PubMed ID: 32066565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
    Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS
    PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative genome-scale analysis of immune infiltration in esophageal carcinoma.
    Bian Y; Bi G; Wei T; Yao G; Chen Z; Zhan C; Fan H
    Int Immunopharmacol; 2021 Apr; 93():107371. PubMed ID: 33535118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CCL20-CCR6 Axis in Cancer Progression.
    Kadomoto S; Izumi K; Mizokami A
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
    Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
    J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased IL-17-producing CD4(+) T cells in patients with esophageal cancer.
    Chen D; Hu Q; Mao C; Jiao Z; Wang S; Yu L; Xu Y; Dai D; Yin L; Xu H
    Cell Immunol; 2012; 272(2):166-74. PubMed ID: 22082565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.
    Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W
    Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis.
    Zhang X; Peng L; Luo Y; Zhang S; Pu Y; Chen Y; Guo W; Yao J; Shao M; Fan W; Cui Q; Xi Y; Sun Y; Niu X; Zhao X; Chen L; Wang Y; Liu Y; Yang X; Wang C; Zhong C; Tan W; Wang J; Wu C; Lin D
    Nat Commun; 2021 Sep; 12(1):5291. PubMed ID: 34489433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGFR/Ras-induced CCL20 production modulates the tumour microenvironment.
    Hippe A; Braun SA; Oláh P; Gerber PA; Schorr A; Seeliger S; Holtz S; Jannasch K; Pivarcsi A; Buhren B; Schrumpf H; Kislat A; Bünemann E; Steinhoff M; Fischer J; Lira SA; Boukamp P; Hevezi P; Stoecklein NH; Hoffmann T; Alves F; Sleeman J; Bauer T; Klufa J; Amberg N; Sibilia M; Zlotnik A; Müller-Homey A; Homey B
    Br J Cancer; 2020 Sep; 123(6):942-954. PubMed ID: 32601464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
    Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcription factor RUNX3 promotes CD8
    Song Q; Shang J; Zhang C; Chen J; Zhang L; Wu X
    J Cell Biochem; 2020 Jun; 121(5-6):3208-3220. PubMed ID: 31898342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enrichment of Human CCR6
    Lee JJ; Kao KC; Chiu YL; Jung CJ; Liu CJ; Cheng SJ; Chang YL; Ko JY; Chia JS
    J Immunol; 2017 Jul; 199(2):467-476. PubMed ID: 28600287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
    Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
    Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.
    Chen Y; Wang D; Peng H; Chen X; Han X; Yu J; Wang W; Liang L; Liu Z; Zheng Y; Hu J; Yang L; Li J; Zhou H; Cui X; Li F
    Mol Cancer; 2019 Jan; 18(1):1. PubMed ID: 30609930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis.
    Wu YY; Tsai HF; Lin WC; Hsu PI; Shun CT; Wu MS; Hsu PN
    Infect Immun; 2007 Sep; 75(9):4357-63. PubMed ID: 17562763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.